Katherine (Kathy) Pappas focuses her practice on intellectual property matters, particularly in patent litigation within the life sciences sector. Kathy handles matters involving a large variety of technologies, ranging from mechanical inventions (e.g., microfluidic devices; injector pens) to pharmaceutical litigation under the Hatch-Waxman Act.
Referenzmandate
- Assisted trial team in obtaining a verdict finding an injector pen for insulin delivery did not infringe Sanofi’s patent, and further finding Sanofi’s patent invalid (Sanofi-Aventis v. Mylan (D.N.J.))*
*Matter handled prior to joining the firm.
Internationale Märkte
Qualifikation
Education
- University of California, Los Angeles School of Law, JD
- Hampshire College, BA, Psychology with a minor in Cognitive Neuroscience
Admissions
- California
Courts / Agencies
- US District Court for the Southern District of California